Lithium citrate
RxNorm 52105
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 52105 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lithium citrate.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Lithium citrate
(Atom ID: 521565)
PTPrescribable
Designated preferred name (PT):
Lithium citrate
(Atom ID: 521571)
FNPrescribable
Full form of descriptor (FN):
Lithium citrate (substance)
(Atom ID: 521577)
PTPrescribable
Designated preferred name (PT):
Lithium citrate-containing product
(Atom ID: 10806162)
FNPrescribable
Full form of descriptor (FN):
Product containing lithium citrate (medicinal product)
(Atom ID: 9724796)
Patient Education
Lithium
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
[Learn More]
* Please review the disclaimer below.